Lifestyle and clinical factors could have been misinterpreted, linking antibiotics to risk of diabetes.
Sulfonylureas and thiazolidinediones adherence was stronger than metformin adherence.
Diabetic patients with chronic kidney disease starting treatment with metformin have a 36% decreased risk of death compared with those starting on a sulfonylurea, study finds.
From 1995 to 2015, the prevalence of hypertension and diabetes among patients starting hemodialysis increased from 67.9% to 87.6% and from 43.1% to 59.6%, respectively.
The incidence of NODAT was 33.8% among patients who switched to everolimus and 36.4% among those who stayed on calcineurin inhibitors.
The adjusted 5-year risk of insulin use following donation is 5 times higher among obese vs normal weight donors.
Combination therapy was effective in lowering the HbA1c independent of sex, ethnicity, BMI, or baseline HbA1c.
In patients with diabetes, deferred revascularization is associated with poor medium-term outcomes